Iruzubieta, P, Verdú-Díaz, J, Töpf, A, Luce, L, Claeys, KG, De Ridder, W, González-Quereda, L, de la Hoz, CPD, Poza, JJ, Zulaica, M, de Jonghe, P, Duff, J, Mroczek, M, Martín-Jiménez, P, Hernández-Laín, A, Domínguez-González, C, Baets, J, Gallano, P, Díaz-Manera, J, Straub, V, de Munain, AL, Fernandez-Torron, R. Clinical and imaging spectrum of non-congenital dominant ACTN2 myopathy. JOURNAL OF NEUROLOGY. 2025; 272(2)DOI:10.1007/s00415-025-12893-9. PMID:39812845. IF:4.600(Q1/2D).

Gutiérrez-Muñoz, C, Blázquez-Serra, R, San Sebastian-Jaraba, I, Sanz-Andrea, S, Fernández-Gómez, MJ, Nuñez-Moreno, G, Mínguez, P, Escolá-Gil, JC, Nogales, P, Ollivier, V, Martín-Ventura, JL, Noe, BHT, Rescher, U, Méndez-Barbero, N, Blanco-Colio, LM. Annexin A8 deficiency delays atherosclerosis progression. Clinical and Translational Medicine. 2025; 15(1)DOI:10.1002/ctm2.70176. PMID:39835780. IF:6.800(Q1/2D).

Canyelles M, Blanco-Vaca F, Pérez A, Escolà-Gil JC. Comment on Huh et al. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care 2023;46:305-312.. DIABETES CARE. 2023; 46(10)DOI:10.2337/dc23-0774. PMID:37729500. IF:(Q/D).

Teis A, Castelblanco E, Cediel G, Amigó N, Julve J, Ribalta J, Guardiola M, Franch J, Bermúdez-López M, Codina P, Lupón J, Mauricio D, Alonso N, Bayés-Genís A. (1)H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls.. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(11)DOI:10.1016/j.rec.2021.09.008. PMID:34716123. IF:(Q/D).

Llena-Meler, M, Canfran-Duque, A, Madrigal-Matute, J, Rotllan, N. Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease. SEMINARS IN CANCER BIOLOGY. 2026; 119DOI:10.1016/j.semcancer.2026.01.003. PMID:41520912. IF:15.700(Q1/1D).

Mallén, A, Rotllan, N, Griñán, R, Varela, C, Bertolino, E, Paloschi, V, Maegdefessel, L, Escolà-Gil, JC, Aran, JM, Sbraga, F, Blasco-Lucas, A, Torras, J, Navarro, E, Hueso, M. In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY. 2026; 330(1)DOI:10.1152/ajpcell.00242.2025. PMID:41289597. IF:4.700(Q1/1D).

Chaparro-Cabanillas, N, Pedragosa, J, Núñez-Moyano, H, Escolà-Gil, JC, Planas, AM. Effects of Chronic High-Fat Diet and Pemafibrate Treatment on Stroke Outcomes. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025; 45(1)DOI:. PMID:. IF:4.500(Q1/2D).

Mercè, F, Asla, Q, Illana, FJ, Victòria, F, Javier, HL, Marta, S, Iglesias, C, Webb, SM, Aulinas, A. A novel likely pathogenic germline variant in CDKN1B in a patient with MEN4 and medullary thyroid cancer. Familial Cancer. 2025; 24(1)DOI:10.1007/s10689-025-00449-9. PMID:40009226. IF:2.000(Q3/7D).

Téllez, L, Donate, J, Guerrero, A, Beraza, IA, San Martín, D, Alvarado, E, Echevarria, V, Puente, A, Zamora, J, Del Prado, S, Tenes, A, Balagué, G, Vidal, B, Geli, C, Rodriguez-Gandia, MA, Baiges, A, Brujats, A, Rodríguez, DLH, Sánchez, SFG, Fortea, JI, del Cerro, MJ, Villanueva, C, Garcia-Pagán, JC, Giráldez, A, Albillos, A. Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the PORTO-DETECT cohort. JOURNAL OF HEPATOLOGY. 2026; 84(2)DOI:10.1016/j.jhep.2025.09.011. PMID:41076090. IF:33.000(Q1/1D).

Arguello-Tomas, M, Lynton-Pons, E, Albiol, N, Lopez-Ferrer, A, Sierra, J, Moga, E, Moreno, C. Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia. CANCER. 2025; 131(24)DOI:10.1002/cncr.70216. PMID:41378669. IF:5.100(Q1/3D).

Rudler, M, Gea, VH, Larrue, H, Bouzbib, C, Procopet, B, Baiges, A, Turon, F, Villanueva, C, Albillos, A, Tapias, EA, Gluud, LL, Praktiknjo, M, Genesca, J, Ventura-Cots, M, Villagrasa, A, Rodrigues, S, Mouri, S, Giráldez-Gallego, A, Ridaura, HM, Laleman, W, Bureau, C, Robic, MA, Hartl, L, Tellez, L, Zipprich, A, Canete, N, Sultanik, P, Deckmyn, O, Mandorfer, M, Senzolo, M, Schepis, F, Tripathi, D, Pagan, JCG, Thabut, D. Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis. Jhep Reports. 2025; 7(12)DOI:10.1016/j.jhepr.2025.101611. PMID:41362711. IF:7.500(Q1/2D).

Serra, E, Cantó, E, Gely, C, Pont, M, Trincado, J, Crespo, M, Vidal, S, Puig, L. Baseline Plasma Protein Signatures and Differential Molecular Responses to Dupilumab in Atopic Dermatitis Patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2025; 145(12)DOI:. PMID:. IF:5.700(Q1/1D).

Martín-Aguilar, L, Blanco-Sanromán, N, Appiani, FE, Caballero-Avila, M, Vidal, N, Martínez-Martínez, L, Querol, L, Vidal-Jordana, A. Personalized dosing in MS: extended interval dosing of ocrelizumab, a real-world observational study. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).

Osuna-Gómez, R, Zamora, C, Novelli, S, Garcia-Pallarols, F, Rodriguez, Y, Domingo, A, Canet, M, Olivera, P, Mulet, M, Cantó, E, Valcarcel, D, Sanchez-Gonzalez, B, Vidal, S. Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients. BRITISH JOURNAL OF HAEMATOLOGY. 2025; 206(4)DOI:10.1111/bjh.19779. PMID:39327831. IF:3.800(Q1/3D).

Arguello-Tomas, M, Mozas, P, Albiol, N, López-Esteban, M, Sierra, J, Nomdedéu, J, Martinez-Laperche, C, Moga, E, Piñeyroa, JA, Delgado, J, Osorio, S, Moreno, C. Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy. CANCER. 2025; 131(1)DOI:10.1002/cncr.35552. PMID:39264834. IF:5.100(Q1/3D).

Laghi L, Román E, Lan Q, Nieto JC, Canalda-Baltrons A, Poca M, Sánchez-Rodríguez MB, Clària J, Alvarado E, Cuyàs B, Sánchez E, Vidal S, Guarner C, Escorsell À, Manichanh C, Soriano G. A multistrain probiotic increases the serum glutamine/glutamate ratio in patients with cirrhosis: a metabolomic analysis.. Hepatology Communications. 2023; 7(4)DOI:10.1097/HC9.0000000000000072. PMID:37026745. IF:5.600(Q1/2D).

Lima, RA, Desoye, G, Simmons, D, van Poppel, MNM, Corcoy R., Adelantado J.M., Jelsma, Judith G.M.. Mediators of lifestyle intervention effects on neonatal adiposity: are we missing a piece of the puzzle?. PEDIATRIC RESEARCH. 2022; 91(3)DOI:10.1038/s41390-021-01450-5. PMID:33753890. IF:3.600(Q1/2D).

Rodríguez-Padial L, Pérez A, Anguita Sánchez M, Barrios V, Gimeno-Orna JA, Muñiz J. Characteristics of women with type 2 diabetes and heart failure in Spain. The DIABET-IC study.. Cardiology Journal. 2024; 31(1)DOI:10.5603/CJ.a2023.0016. PMID:36896635. IF:1.900(Q3/6D).

Monroy G, Fernández C, Olmo R, Martínez MJ, DE Leiva A, Corcoy R. Breastfeeding is associated with a delayed decrease in postprandial maternal glucose concentration.. Minerva Endocrinology. 2023; 48(4)DOI:10.23736/S2724-6507.23.03962-3. PMID:37158811. IF:(Q/D).

Ortega E, Vlacho B, Treserres RP, Mata-Cases M, Altes A, Mauricio D, Franch-Nadal J. Severe hypertriglyceridemia prevalence at a primary care setting in Catalonia, Spain.. Journal of Clinical Lipidology. 2023; 17(6)DOI:10.1016/j.jacl.2023.09.002. PMID:37741728. IF:(Q/D).

Tobias DK, Merino J, Ahmad A, Aiken C, Benham JL, Bodhini D, Clark AL, Colclough K, Corcoy R, Cromer SJ, Duan D, Felton JL, Francis EC, Gillard P, Gingras V, Gaillard R, Haider E, Hughes A, Ikle JM, Jacobsen LM, Kahkoska AR, Kettunen JLT, Kreienkamp RJ, Lim LL, Männistö JME, Massey R, Mclennan NM, Miller RG, Morieri ML, Most J, Naylor RN, Ozkan B, Patel KA, Pilla SJ, Prystupa K, Raghavan S, Rooney MR, Schön M, Semnani-Azad Z, Sevilla-Gonzalez M, Svalastoga P, Takele WW, Tam CH, Thuesen ACB, Tosur M, Wallace AS, Wang CC, Wong JJ, Yamamoto JM, Young K, Amouyal C, Andersen MK, Bonham MP, Chen M, Cheng F, Chikowore T, Chivers SC, Clemmensen C, Dabelea D, Dawed AY, Deutsch AJ, Dickens LT, DiMeglio LA, Dudenhöffer-Pfeifer M, Evans-Molina C, Fernández-Balsells MM, Fitipaldi H, Fitzpatrick SL, Gitelman SE, Goodarzi MO, Grieger JA, Guasch-Ferré M, Habibi N, Hansen T, Huang C, Harris-Kawano A, Ismail HM, Hoag B, Johnson RK, Jones AG, Koivula RW, Leong A, Leung GKW, Libman IM, Liu K, Long SA, Lowe WL Jr, Morton RW, Motala AA, Onengut-Gumuscu S, Pankow JS, Pathirana M, Pazmino S, Perez D, Petrie JR, Powe CE, Quinteros A, Jain R, Ray D, Ried-Larsen M, Saeed Z, Santhakumar V, Kanbour S, Sarkar S, Monaco GSF, Scholtens DM, Selvin E, Sheu WH, Speake C, Stanislawski MA, Steenackers N, Steck AK, Stefan N, Støy J, Taylor R, Tye SC, Ukke GG, Urazbayeva M, Van der Schueren B, Vatier C, Wentworth JM, Hannah W, White SL, Yu G, Zhang Y, Zhou SJ, Beltrand J, Polak M, Aukrust I, de Franco E, Flanagan SE, Maloney KA, McGovern A, Molnes J, Nakabuye M, Njølstad PR, Pomares-Millan H, Provenzano M, Saint-Martin C, Zhang C, Zhu Y, Auh S, de Souza R, Fawcett AJ, Gruber C, Mekonnen EG, Mixter E, Sherifali D, Eckel RH, Nolan JJ, Philipson LH, Brown RJ, Billings LK, Boyle K, Costacou T, Dennis JM, Florez JC, Gloyn AL, Gomez MF, Gottlieb PA, Greeley SAW, Griffin K, Hattersley AT, Hirsch IB, Hivert MF, Hood KK, Josefson JL, Kwak SH, Laffel LM, Lim SS, Loos RJF, Ma RCW, Mathieu C, Mathioudakis N, Meigs JB, Misra S, Mohan V, Murphy R, Oram R, Owen KR, Ozanne SE, Pearson ER, Perng W, Pollin TI, Pop-Busui R, Pratley RE, Redman LM, Redondo MJ, Reynolds RM, Semple RK, Sherr JL, Sims EK, Sweeting A, Tuomi T, Udler MS, Vesco KK, Vilsbøll T, Wagner R, Rich SS, Franks PW. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.. NATURE MEDICINE. 2023; 29(10)DOI:10.1038/s41591-023-02502-5. PMID:37794253. IF:58.700(Q1/1D).

Falkenhain-López D, Muniesa C, Estrach MT, Morillo-Andújar M, Peñate Y, Acebo E, Pujol RM, García-Muret MP, Machan S, Medina S, Botella-Estrada R, Fernández de Misa R, Blanes M, Flórez A, Pérez-Paredes G, Izu R, Yanguas I, Silva-Díaz E, Pérez-Ferriols A, Prieto-Torres L, Zayas A, Parera-Amer ME, Pérez A, Aspe L, Román C, Sánchez-Caminero MP, Bassas-Vila J, Domínguez-Auñón JD, Calzado L, Navedo M, Ortiz-Prieto A, Servitje O, Polo-Rodríguez I, Torres I, Hernández-Hernández MN, Mitxelena-Eceiza J, García-Vázquez A, García-Doval I, Ortiz-Romero PL. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years.. Actas Dermo-Sifiliograficas. 2023; 114(4)DOI:10.1016/j.ad.2022.11.010. PMID:36529273. IF:(Q/D).

Pedro-Botet J, Barrios V, Sánchez-Margalet V, Tamargo J, Arrieta F, Gámez JM, Gimeno-Orna JA, Escobar C, Gómez-Doblas JJ, Pérez A. Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society].. Endocrinologia Diabetes y Nutricion. 2023; 70(Suppl.1)DOI:10.1016/j.endien.2022.11.009. PMID:36402735. IF:1.800(Q3/8D).

Sánchez-Hernández, RM, Ibarretxe, D, Jiménez, FF, Martínez-Hervás, S, Blanco-Echevarria, A, Rodríguez, BC, Rodríguez-Carnero, G, Ordiales, MMM, Pérez, A, González-Bustos, P, Armesto, RA, Sánchez-Sobrino, P, Masana, L, Civeira, F. Homozygous Familial Hypercholesterolemia in Spain: Data From Registry of the Spanish Atherosclerosis Society. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(8)DOI:10.1210/clinem/dgae784. PMID:39514762. IF:5.100(Q1/2D).

Miranda-Olivos, R, Porta-Casteràs, D, de la Peña-arteaga, V, Contreras-Rodríguez, O, Guxens, M, Vrijheid, M, Cardoner, N, Cano, M. Thalamic-Basal Ganglia Connectivity Patterns as a Sex-Specific Vulnerability Factor to OCD Symptomatology in Healthy Adolescents. BIOLOGICAL PSYCHIATRY. 2025; 97(9)DOI:. PMID:. IF:9.000(Q1/1D).

Mendoza, LC, Cohen, O, Smaniotto, V, Corcoy, R. Switching to insulin lispro U-200 in a pregnant woman using a 780G advanced hybrid closed-loop led to a rapid improvement in glucose metrics. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 222DOI:10.1016/j.diabres.2025.112047. PMID:39961514. IF:7.400(Q1/1D).

Gonzalez-Manzanares, R, Anguita-Gámez, M, Muñiz, J, Barrios, V, Gimeno-Orna, JA, Pérez, A, Rodríguez-Padial, L, Anguita, M. Sex Differences in the Diagnosis and Management of Heart Failure Among Outpatients with Type 2 Diabetes. JOURNAL OF WOMENS HEALTH. 2026; 35(3)DOI:10.1177/15409996251401741. PMID:41449991. IF:1.900(Q1/2D).

Torres, G, Gracia-Lavedan, E, González, J, Henríquez-Beltrán, M, Targa, ADS, Royo, M, Bermúdez-López, M, Castro-Boqué, E, Valdivielso, JM, Pamplona, R, Mauricio, D, Lecube, A, Barbé, F, De Batlle, J, Miquel, E, Ortega, M, Portero-Otín, M, Jové, M, Hernández, M, Rius, F, Franch-Nadal, J, Castelblanco, E, Godoy, P, Martinez-Alonso, M, Simó, R, Hernández, C, Fernández, E. Skin advanced glycation end-products do not predict pulmonary function trajectories in adults from the ILERVAS cohort. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-025-33414-8. PMID:41535697. IF:3.900(Q1/2D).

León-Mengíbar, J, Malagón, MM, Bermúdez-López, M, Valdivielso, JM, Pamplona, R, Torres, G, Mauricio, D, Castro, E, Fernández, E, Caixàs, A, Hernández, M, Lopez-Cano, C, Gordon, A, Guzman-Ruiz, R, Cusi, K, Lecube, A. Association of estimated liver fibrosis with carotid but not femoral atherosclerotic burden: the ILERVAS cohort. Frontiers in Endocrinology. 2026; 16DOI:10.3389/fendo.2025.1651689. PMID:41567808. IF:4.600(Q1/3D).

Xie, XL, Liu, JM, López, A, Garcia-Patterson, A, Adelantado, JM, López, E, Corcoy, R. In women with pre-existing diabetes, the contribution to pregnancy outcomes of gestational weight gain as defined by IOM guidelines, differs when adjustment for gestational age is used. ACTA DIABETOLOGICA. 2026; 63(1)DOI:10.1007/s00592-025-02587-z. PMID:41055719. IF:2.900(Q3/6D).

Navarro-González, JF, de Isla, LP, Molina, GC, Brito-Sanfiel, MA, Galindo, DEB, Olmedo, LAC, Mauricio, D, Povedano, ST, Barro, JAB, Almanza, MR, Sánchez, JJA, Mutiozabal, MS, Pimentel, B, Domínguez, AP, Arias-Cabrales, C, Fanjul, V, Blanco-Carrasco, AJ, Torres, JFM. Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data. Kidney Diseases. 2026; 12(1)DOI:10.1159/000547604. PMID:41510180. IF:3.100(Q1/3D).

Ritzel, R, Davies, MJ, Hao, LC, Ji, LN, Lintu, MK, Mabunay, A, Mauricio, D, Bailey, T. Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study. Diabetes Therapy. 2026; 17(1)DOI:10.1007/s13300-025-01798-5. PMID:41269514. IF:2.600(Q3/6D).

Miñana-Castellanos, M, Granés, MR, Camins, BF, Méndez, EN, Puente, JBD, Estella, CL. Management of type 2 diabetes mellitus in frail patients from the Perspective of Real-World Clinical Practice. Atencion Primaria. 2026; 58(1)DOI:10.1016/j.aprim.2025.103399. PMID:41494416. IF:1.600(Q2/4D).

Julve, J, Rodriguez-Calvo, R, Perret, B, Martinez, LO, Mauricio, D. Targeting Atherosclerosis: Cholesterol-Lowering Therapies with a New Immunometabolic Dress for an Old Disease. Journal of Clinical Medicine. 2025; 14(24)DOI:10.3390/jcm14248777. PMID:41464678. IF:2.900(Q1/2D).

Barranco-Altirriba, M, Granado-Casas, M, Yanes, O, Capellades, J, Junza, A, Franch-Nadal, J, Vendrell, J, Llaurado, G, Valdés, S, García-Escobar, E, Bermúdez-Lopez, M, Valdivielso, JM, Lopez-Lifante, VM, Herrero-Alonso, C, Falguera, M, Vilanova, MB, Arteaga, I, Torán-Monserrat, P, Perera-Lluna, A, Castelblanco, E, Mauricio, D. Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations. Frontiers in Endocrinology. 2025; 16DOI:10.3389/fendo.2025.1706886. PMID:41416067. IF:4.600(Q1/3D).

Khan-Miron, A, Syleouni, ME, Brusaferri, G, Nyffeler, M, Chico, A, Moreno-Fernandez, J, Beato-Víbora, PI. Clinical and Economic Impact of Hybrid Closed-Loop Systems for T1 Diabetes Management in Spain. Endocrine Practice. 2025; 31(12)DOI:10.1016/j.eprac.2025.08.002. PMID:40774615. IF:4.600(Q1/3D).

Barrot-de la Puente, J, Arpí, CL, Granes, MR, Planes, ME, Fernandez-Camins, B, Vlacho, B, Franch-Nadal, J. Chronic kidney disease screening in primary care: a descriptive analysis of the Girona Sud health region. Bmc Primary Care. 2025; 26(1)DOI:10.1186/s12875-025-03117-0. PMID:41276836. IF:2.600(Q1/1D).

Corcoy, R, Mendoza, LC, Serrano, AC, Bonet, M, Mart nez, A, Romero, M, Safont, E, Pujol, I, Lopez, A. International Diabetes Federation 2024 criteria: impact on the postpartum glucose tolerance assessment of women with gestational diabetes. DIABETOLOGIA. 2025; 68DOI:. PMID:. IF:10.200(Q1/1D).

Mesa, A, Puig-Jov , C, Pan , A, Vinagre, I, L pez-Quesada, E, Meler, E, Alonso-Carril, N, Quir s, C, Amor, A, Perea, V. Pre-eclampsia is an independent predictor of atherosclerosis progression in women with type 1 diabetes: a 5 year prospective study. DIABETOLOGIA. 2025; 68DOI:. PMID:. IF:10.200(Q1/1D).

Vi als, C, Conget, I, Granados, M, Sol , C, Mesa, A, Ser s-Noriega, T, Perea, V, Blanco, J, Vinagre, I, Gim nez, M, Amor, A. Impact of cardiovascular risk factors control on atherosclerosis progression in individuals with type 1 diabetes. DIABETOLOGIA. 2025; 68DOI:. PMID:. IF:10.200(Q1/1D).